Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Quantitative risk factor analysis of prior disease condition and socioeconomic status with the multiple myeloma development: nationwide cohort study.
Sci Rep. 2024 Feb 28;14(1):4885. doi: 10.1038/s41598-024-52720-1.
Sci Rep. 2024.
PMID: 38418448
Free PMC article.
Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study.
Lee JY, Park SS, Jeon YW, Shin SH, Yahng SA, Min CK; Catholic Research Network for Multiple Myeloma (CAREMM-2102 study).
Lee JY, et al.
J Cancer Res Clin Oncol. 2023 Oct;149(13):11907-11918. doi: 10.1007/s00432-023-04993-8. Epub 2023 Jul 7.
J Cancer Res Clin Oncol. 2023.
PMID: 37418057
Item in Clipboard
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma.
Park SS, Lee JC, Byun JM, Choi G, Kim KH, Lim S, Dingli D, Jeon YW, Yahng SA, Shin SH, Min CK, Koo J.
Park SS, et al.
NPJ Precis Oncol. 2023 May 20;7(1):46. doi: 10.1038/s41698-023-00385-w.
NPJ Precis Oncol. 2023.
PMID: 37210456
Free PMC article.
Item in Clipboard
Cite
Cite